Mirtazapine Almus

Mirtazapine, the active ingredient in Mirtazapine Almus, is a NaSSA (noradrenergic and specific serotonergic antidepressant) presented as an oral tablet for oral use. It is prescribed for the treatment of major depressive disorder in adult patients.

GNH USA supplies Mirtazapine Almus as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides regulatory documentation to support global distribution. Customers benefit from reliable logistics and responsive technical support throughout the supply chain.

Mirtazapine is an antidepressant that acts on noradrenergic and serotonergic pathways to improve mood in depressive disorders.

- Major depressive disorder: alleviates depressive symptoms and improves functional outcomes in adult patients.

Mirtazapine may cause a range of adverse reactions, which are categorized by frequency and severity.

Common Side Effects: - Sedation: drowsiness or sleepiness, especially at treatment initiation. - Increased appetite: often leading to weight gain. - Dry mouth: reduced salivation causing discomfort. - Dizziness: light‑headed sensation upon standing.

Serious or Rare Side Effects: - Agranulocytosis: severe reduction in white blood cells. - Stevens‑Johnson syndrome: rare but serious skin reaction. - Suicidal ideation: emergence or worsening of suicidal thoughts, particularly early in therapy.

When prescribing mirtazapine, clinicians should consider several safety precautions to minimize risk.

- Liver function: assess hepatic impairment before initiating therapy. - Weight monitoring: observe for significant weight gain during treatment. - Elderly patients: start at low dose and monitor for sedation. - Discontinuation: avoid abrupt cessation to reduce withdrawal symptoms. - Suicidal ideation: monitor for emergence of suicidal thoughts, especially early in treatment. - Store at ambient temperature: keep below 25 °C in the original container, protect from moisture and light.

Mirtazapine can interact with other medicines, altering its effectiveness or increasing adverse effects.

Major Interactions (Avoid): - MAO inhibitors: risk of hypertensive crisis and serotonin syndrome. - Other serotonergic agents (e.g., SSRIs, SNRIs): increased potential for serotonin syndrome. - CNS depressants (e.g., alcohol, benzodiazepines): additive sedation and respiratory depression.

Moderate Interactions (Monitor Closely): - CYP2D6 inhibitors (e.g., fluoxetine, paroxetine): may raise mirtazapine plasma levels. - Antihypertensives: possible additive hypotensive effect.